Mednet Logo

What is your approach to a positive PPD or IGRA in a patient with well-controlled HIV without significant TB risk factors?

Community PollStarted

Would you treat a patient with well-controlled HIV who has a positive PPD or IGRA but no significant TB risk factors?

115 physicians have voted

Join Mednetto vote and see how they answered.

5 Answers
Mednet Member
Mednet MemberInvited Expert
Infectious Disease · Idaho Department Of Health And Welfare
Answered on

I would treat this patient for LTBI (after ruling out active disease); if the patient was hesitant to be treated, a second test could be done if it would increase their likelihood of adhering to the regimen; but I would urge treatment in any case as the stakes are high if untreated LTBI is present.

...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Infectious Disease · Beebe Infectious Disease
Answered on

I treat all HIV patients with positive screening tests. I consider HIV itself, regardless of CD4 count, to be the highest risk for reactivation disease. I believe there is data showing this risk to be higher even than organ transplant or cancer treatment patients.

The problem, of course, is navigati...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Infectious Disease · Pacific Inpatient Medical Group
Answered on

In an HIV patient without significant risk factors (CD4 nadir >300, no comorbidities), I would offer and encourage treatment for latent Tb but probably not push too hard. For patients who who were willing, I would offer 4 months of rifampin. This would often necessitate changing their ART to doluteg...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Infectious Disease · Westchester County Healthcare Corp
Answered on · Updated on

The question here is treating a disease (Latent tuberculosis) vs treating a test result.

  1. While a positive TB quantiferon or IGRA helps, the final diagnosis of LTBI also depends on the additional evidence of epidemiological risk and/or radiological findings.
  2. Not all positive TB quantiferon results ...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Infectious Disease · Saint Francis Hospital
Answered on

As with most of medicine, it’s risk vs benefit. If the LTBI regimen is well-tolerated with few/no drug interactions would provide INH/Rifapentin weekly x 12, Rifampin x 4 months, INH/rifampin x 3 months, whatever, depending on patient preference. If poorly tolerated, inform the patient and just note...

Join for free or sign in to see the full answer